Agenda

  • 14:30
    Registration and networking
  • 15:00
    Welcome by Hans Schambye, Chairman - DANSK BIOTEK & Nils Bang, Partner – Gorrissen Federspiel
  • 15:10
    AMR surveillance, research and development by Robert Skov, National AMR Coordinator, Division of Infectious Disease Preparedness and Carina Vingsbo Lundsbo, Head of Preclinical Development of Antimicrobials - Statens Serum Institut
  • 15:30
    The CRISPR approach in life threatening diseases with AMR bacteria by Lene Jessen, VP, Head of In vivo Pharmacology & Toxicology - SNIPR Biome
  • 15:50
    Leveraging small molecules to tackle resistance by Rasmus Toft-Kehler, CEO - UNION therapeutics A/S
  • 16:10
    Developing vaccines for antibiotic resistance by Per Fischer, CEO - MinervaX ApS
  • 16:30
    The REPAIR Impact Fund by Aleks Engel, Partner – Novo Seeds
  • 17:00
    Networking and snacks
  • SeptMeeting2019 DANSKBIOTEK

DANSK BIOTEK members’ meeting: Antibiotic Resistance – Improving the Effectiveness of Antibiotics

starts:09/09/2019 ends:09/09/2019 from:14:30 to:17:30 address:Gorrissen Federspiel Advokatpartnerselskab, Axeltorv, CPH V mobile:+4551500560 email: dd@danskbiotek.dk price:Free of charge for members; non-members: 500 DKK Import to calendar
adresse:
Gorrissen Federspiel Advokatpartnerselskab, Axeltorv, CPH V
Get directions

Venue: Gorrissen Federspiel Advokatpartnerselskab, Axeltorv, CPH V

Date: 09/09/2019

Time: 14:30 - 17:30

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2019 Danskbiotek. All rights reserved.